Report
Kristoffer Inton
EUR 101.80 For Business Accounts Only

Paracatu Weighs on Otherwise Strong Quarter; Kinross on Track to Hit Full-Year Guidance

Kinross reported strong operational performance in the third quarter of 2017 that was partially marred by temporary challenges at its Paracatu mine in Brazil. With the exception of Kettle River-Buckhorn and Maricunga, which are at the end of their mine lives, Kinross’ mines all saw production increase. However, Paracatu saw a major decline in production, as the mine was off line from July through October due to below average rainfall. However, we don’t see this as a long-term challenge, especial...
Underlying
Kinross Gold Corporation

Kinross Gold is engaged in the mining and processing of gold and, as a by-product, silver ore and the exploration for, and the acquisition of, gold bearing properties in the Americas, the Russian Federation, West Africa and worldwide. As of Dec 31 2013, Co.'s proven mineral reserves for gold and silver were 1,122 ounces and 1,179 ounces respectively.7,883 7,883 7,883

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Kristoffer Inton

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch